Horizon Bancorp Inc /In/ Laboratory Corp Of America Holdings Transaction History

Horizon Bancorp Inc /In/

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$209.01 - $232.56 $1,672 - $1,860	-8 Reduced 5.67%	133 $29,000
Q3 2023 Oct 24, 2023	SELL	$201.05 - $221.7 $13,671 - $15,075	-68 Reduced 32.54%	141 $28,000
Q2 2023 Aug 03, 2023	SELL	$211.93 - $241.33 $86,043 - $97,979	-406 Reduced 66.02%	209 $50,000
Q1 2023 May 05, 2023	SELL	$213.32 - $257.83 $4,053 - $4,898	-19 Reduced 3.0%	615 $141,000
Q4 2022 Feb 09, 2023	SELL	$203.72 - $248.97 $77,006 - $94,110	-378 Reduced 37.35%	634 $149,000
Q3 2020 Nov 12, 2020	SELL	$167.03 - $201.3 $8,017 - $9,662	-48 Reduced 4.53%	1,012 $191,000
Q2 2020 Aug 10, 2020	SELL	$113.31 - $182.44 $10,084 - $16,237	-89 Reduced 7.75%	1,060 $176,000
Q1 2020 Apr 20, 2020	SELL	$104.32 - $195.28 $31,921 - $59,755	-306 Reduced 21.03%	1,149 $145,000
Q4 2019 Feb 11, 2020	BUY	$163.48 - $173.61 $237,863 - $252,602	1,455 New	1,455 $246,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.